You are here: Home: CCU for Surgeons 1 | 2006: Editor's Note

For more than 20 years, our CME group, Research To Practice, has been producing cancer education programs for medical oncologists. The centerpiece of our educational offerings has always been the Cancer Update audio series, featuring one-on-one interviews with clinical investigators that bridge the gap between research and patient care. Currently, more than two thirds of the medical oncologists in the United States regularly listen to our audio education programs.

In recent years, we have also developed programs for surgeons that delve not only into surgical issues but also into the role of systemic therapy in the management of early and metastatic disease. This new series in colorectal cancer joins our breast cancer surgical series. Rapidly emerging clinical research in both tumor types has significantly changed clinical care of patients with these tumors.

Never before has the multidisciplinary management of colorectal cancer been more important. In recent years, the availability of a number of new and effective chemotherapeutic and biologic agents has caused an explosion in treatment options for patients with both primary and metastatic disease. To that end, our goal for this new series is to help surgeons understand the latest developments in clinical research and enable them to apply practical management strategies to daily patient care.

In this program, we cover a number of important topics: Dr John Marshall discusses the curability of colon cancer with oligometastatic disease, Dr Lawrence Wagman reviews the current NSABP study examining the role of hepatic arterial infusion of chemotherapy following liver resection, Dr Robert Wolff shares his perspectives on the latest research findings with adjuvant chemotherapy and his suggested algorithm for referring patients with Stage II disease for a medical oncology consultation and Dr Douglas Wong provides an overview of the utility of neoadjuvant chemoradiation for patients with rectal cancer.

As with all of our series, we welcome your input and suggestions and hope you enjoy this new program and will continue listening for many years to come.

— Neil Love, MD
NLove@ResearchToPractice.net


Home


Table of Contents

Editor's Note

CME Information

Faculty Disclosures

Editor's Office